High level heterologous expression in E. coli using the anaerobically-activated nirB promoter
- PMID: 2057350
- PMCID: PMC328247
- DOI: 10.1093/nar/19.11.2889
High level heterologous expression in E. coli using the anaerobically-activated nirB promoter
Abstract
The anaerobically-regulated nirB promoter was used to express heterologous genes in Escherichia coli. Under anaerobic conditions the promoter was able to express tetanus toxin fragment C at approximately 20% total cell protein (tcp) and the Bordetella pertussis antigen pertactin at greater than 30% tcp. These levels are comparable to those obtained for the same products using the tac promoter. The nirB promoter is very well regulated, giving almost two orders of magnitude increase in fragment C on complete removal of oxygen. The use of this anaerobically-induced promoter in the production of recombinant proteins in E. coli is discussed.
Similar articles
-
High level heterologous expression in E. coli using mutant forms of the lac promoter.Nucleic Acids Res. 1991 May 11;19(9):2417-21. doi: 10.1093/nar/19.9.2417. Nucleic Acids Res. 1991. PMID: 2041779 Free PMC article.
-
Studies of the anaerobically induced promoter pnirB and the improved expression of bacterial antigens.Res Microbiol. 1995 Mar-Apr;146(3):193-202. doi: 10.1016/0923-2508(96)80275-0. Res Microbiol. 1995. PMID: 7569314
-
Mutational analysis of the nucleotide sequence at the FNR-dependent nirB promoter in Escherichia coli.Nucleic Acids Res. 1989 Jan 11;17(1):135-45. doi: 10.1093/nar/17.1.135. Nucleic Acids Res. 1989. PMID: 2536149 Free PMC article.
-
Recombinant protein expression in Escherichia coli.Curr Opin Biotechnol. 1999 Oct;10(5):411-21. doi: 10.1016/s0958-1669(99)00003-8. Curr Opin Biotechnol. 1999. PMID: 10508629 Review.
-
Alternative regulation principles for the production of recombinant proteins in Escherichia coli.Appl Microbiol Biotechnol. 1996 Aug;46(1):1-9. doi: 10.1007/s002530050775. Appl Microbiol Biotechnol. 1996. PMID: 8987528 Review.
Cited by
-
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA.Infect Immun. 1999 Dec;67(12):6424-33. doi: 10.1128/IAI.67.12.6424-6433.1999. Infect Immun. 1999. PMID: 10569759 Free PMC article.
-
T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis.J Exp Med. 2002 Jan 7;195(1):71-84. doi: 10.1084/jem.2001889. J Exp Med. 2002. PMID: 11781367 Free PMC article.
-
In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors.Infect Immun. 2000 Jan;68(1):205-13. doi: 10.1128/IAI.68.1.205-213.2000. Infect Immun. 2000. PMID: 10603389 Free PMC article.
-
Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA.Infect Immun. 1999 Aug;67(8):4290-4. doi: 10.1128/IAI.67.8.4290-4294.1999. Infect Immun. 1999. PMID: 10417208 Free PMC article.
-
Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.Clin Vaccine Immunol. 2010 Apr;17(4):529-36. doi: 10.1128/CVI.00495-09. Epub 2010 Feb 10. Clin Vaccine Immunol. 2010. PMID: 20147499 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources